Citrus Sinensis ID: 011317


Local Sequence Feature Prediction

Prediction and (Method)Result
Residue Number Marker
Protein Sequence ?
Secondary Structure (PSIPRED) ?
Secondary Structure Prediction (SSPRO) ?
Coil and Loop (DISEMBL) ?
Flexible Loop (DISEMBL) ?
Low Complexity Region (SEG) ?
Disordered region (IsUnstruct) ?
Disordered Region (DISOPRED) ?
Disordered Region (DISEMBL) ?
Disordered Region (DISPRO) ?
Transmembrane Helix (TMHMM) ?
Transmembrane Helix (HMMTOP) ?
Transmembrane Helix (MEMSAT) ?
TM Helix, Signal Peptide (MEMSAT_SVM) ?
TM Helix, Signal Peptide (Phobius) ?
Signal Peptide (SignalP HMM Mode) ?
Signal Peptide (SignalP NN Mode) ?
Coiled Coils (COILS) ?
Positional Conservation ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------49
MQGSKALILMFDISLFLRHNFARVWALASEKLTSLEIGYISSVMVTELLSPNVEPHQSPNQIRPSILPGIQKLCLSVDYITDAMVGTISQGLVSLTHLDLRDAPLIEPRITFDLTNSGLQQINQHGKLKHLSLIRSQEFLITYFRRVNDLGILLMADKCASMESICLGGFCRVTDTGFKTILHSCSNLYKLRVSHGTQLTDLVFHDISATSLSLTHVCLRWCNLLTNHAIKSLASNTGIKVLDLRDCKNLGDEALRAISSLPQLKILLLDGSDISDVGVSYLRLTVITSLVKLSLRGCKRLTDKCISALFDGTSKLQLQELDLSNLPHLSDNGILTLATCRVPISELRVRQCPLIGDTSVIALASMLVDDDRWYGSSIRLLDLYNCGGITQLAFRWLKKPYFPRLRWLGVTGSVNRDILDALARSRPFLNVACRGEELGVDQWDNSDGMYMHDYDEVDELEQWLMEGEDESDNDEEMANAEINAEPME
cccccEEEEEEcccccccccHHHHHccccccccccccccccccccccccccccccccccccccccccccccEEEEEcccccHHHHHHHHHccccccEEEEcccccccccccccccHHHHHHHHccccccccccccccEEcccccccccHHHHHHHHHccccccEEEEcccccccHHHHHHHHHccccccEEEccccccccHHHHHHHHHccccccEEEccccccccHHHHHHHHccccccEEEccccccccHHHHHHHcccccccEEEcccccccHHHHHHHHHcccccccEEEccccccccHHHHHHHHcccccccccEEEccccccccHHHHHHHHHccccccEEEEcccccccHHHHHHHHHccccccccccccccEEEccccccccHHHHHHHHccccccccEEEEcccccHHHHHHHHHHcccEEEEEcccccccccccccccccccccccHHHHHHHHHccccccccHHHHHcccccccccc
ccccHHHHHHHcHHccccccHHHHHHHHHHHHHHHHHcccccccEEEEccccccccHHHHHHcccccccHcEEEcccccccHHHHHHHHHccccccEEEcccccccccHHHHHHHHHHHHHHHccccccEEEccccccEcccccccccHHHHHHHHHccccccEEEccccccccHHHHHHHHHHcccccEEEccccccccHHHHHHHHHccccccEEEccccccccHHHHHHHHccccccEEEEcccccccHHHHHHHHcccccEEEEcccccccHHHHHHHHHcccccccEEEccccccccHHHHHHHHccccccccEEEEcccccHccHHHHHHHHHHcccccEEEcccccHccHHHHHHHHHHHHHHHcccccccEEEEcccccHccHHHHHHHHHcccHHHcEEEccccccHHHHHHHHHccccEEEEEccccccccccccccccccccHHHHHHHHHHHHccccccccHHHHHHHcccccccc
MQGSKALILMFDISLFLRHNFARVWALASEKLTSLEIGYISSVMVTEllspnvephqspnqirpsilpgiQKLCLSVDYITDAMVGTISQGLVslthldlrdapliepritfdltnsglqqinqhgkLKHLSLIRSQEFLITYFRRVNDLGILLMADKCasmesiclggfcrvtdtgFKTILHSCSNLYKLRvshgtqltdlVFHDISATSLSLTHVCLRWCNLLTNHAIKslasntgikvldlrdcknlGDEALRAISSLPQLKILlldgsdisdvgVSYLRLTVITSLVKLSLRGCKRLTDKCISALFDgtsklqlqeldlsnlphlsdngiltlatcrvpiselrvrqcpligdTSVIALASMLvdddrwygssirlldlyncggiTQLAFRWlkkpyfprlrwlgvtgsvNRDILDALArsrpflnvacrgeelgvdqwdnsdgmymhdydEVDELEQWLMegedesdndeeMANAeinaepme
MQGSKALILMFDISLFLRHNFARVWALASEKLTSLEIGYISSVMVTELLSPNVEPHQSPNQIRPSILPGIQKLCLSVDYITDAMVGTISQGLVSLTHLDLRDAPLIEPRITFDLTNSGLQQINQHGKLKHLSLIRSQEFLITYFRRVNDLGILLMADKCASMESICLGGFCRVTDTGFKTILHSCSNLYKLRVSHGTQLTDLVFHDISATSLSLTHVCLRWCNLLTNHAIKslasntgikvlDLRDCKNLGDEALRAISSLPQLKILLLDGSDISDVGVSYLRLTVITSLVKLSLRGCKRLTDKCISALFDGTSKLQLQELDLSNLPHLSDNGILTLATCRVPISELRVRQCPLIGDTSVIALASMLVDDDRWYGSSIRLLDLYNCGGITQLAFRWLKKPYFPRLRWLGVTGSVNRDILDALARSRPFlnvacrgeelgvdqwdnsdGMYMHDYDEVDELEQWLMEGEDESDNDEEMANAeinaepme
MQGSKALILMFDISLFLRHNFARVWALASEKLTSLEIGYISSVMVTELLSPNVEPHQSPNQIRPSILPGIQKLCLSVDYITDAMVGTISQGLVSLTHLDLRDAPLIEPRITFDLTNSGLQQINQHGKLKHLSLIRSQEFLITYFRRVNDLGILLMADKCASMESICLGGFCRVTDTGFKTILHSCSNLYKLRVSHGTQLTDLVFHDISATSLSLTHVCLRWCNLLTNHAIKSLASNTGIKVLDLRDCKNLGDEALRAISSLPQLKILLLDGSDISDVGVSYLRLTVITSLVKLSLRGCKRLTDKCISALFDGTSKLQLQELDLSNLPHLSDNGILTLATCRVPISELRVRQCPLIGDTSVIALASMLVDDDRWYGSSIRLLDLYNCGGITQLAFRWLKKPYFPRLRWLGVTGSVNRDILDALARSRPFLNVACRGEELGVDQWDNSDGMYMHDYDEVDELEQWLMEGEDESDNDEEMANAEINAEPME
*****ALILMFDISLFLRHNFARVWALASEKLTSLEIGYISSVMVTELLS*************PSILPGIQKLCLSVDYITDAMVGTISQGLVSLTHLDLRDAPLIEPRITFDLTNSGLQQINQHGKLKHLSLIRSQEFLITYFRRVNDLGILLMADKCASMESICLGGFCRVTDTGFKTILHSCSNLYKLRVSHGTQLTDLVFHDISATSLSLTHVCLRWCNLLTNHAIKSLASNTGIKVLDLRDCKNLGDEALRAISSLPQLKILLLDGSDISDVGVSYLRLTVITSLVKLSLRGCKRLTDKCISALFDGTSKLQLQELDLSNLPHLSDNGILTLATCRVPISELRVRQCPLIGDTSVIALASMLVDDDRWYGSSIRLLDLYNCGGITQLAFRWLKKPYFPRLRWLGVTGSVNRDILDALARSRPFLNVACRGEELGVDQWDNSDGMYMHDYDEVDELEQWL************************
****KALILMFDISLFLRHNFARVWALASEKLTSLEIGYISSVMVTELLSPNVEPHQSPNQIRPSILPGIQKLCLSVDYITDAMVGTISQGLVSLTHLDLRDAPLIEPRITFDLTNSGLQQINQHGKLKHLSLIRSQEFLITYFRRVNDLGILLMADKCASMESICLGGFCRVTDTGFKTILHSCSNLYKLRVSHGTQLTDLVFHDISATSLSLTHVCLRWCNLLTNHAIKSLASNTGIKVLDLRDCKNLGDEALRAISSLPQLKILLLDGSDISDVGVSYLRLTVITSLVKLSLRGCKRLTDKCISALFDGTSKLQLQELDLSNLPHLSDNGILTLATCRVPISELRVRQCPLIGDTSVIALASMLVDDDRWYGSSIRLLDLYNCGGITQLAFRWLKKPYFPRLRWLGVTGSVNRDILDALARSRPFLNVACRGEELGVDQWDNSDGMYMHDYDEVDELEQWLMEGEDESDNDE*************
MQGSKALILMFDISLFLRHNFARVWALASEKLTSLEIGYISSVMVTELLSPNVEPHQSPNQIRPSILPGIQKLCLSVDYITDAMVGTISQGLVSLTHLDLRDAPLIEPRITFDLTNSGLQQINQHGKLKHLSLIRSQEFLITYFRRVNDLGILLMADKCASMESICLGGFCRVTDTGFKTILHSCSNLYKLRVSHGTQLTDLVFHDISATSLSLTHVCLRWCNLLTNHAIKSLASNTGIKVLDLRDCKNLGDEALRAISSLPQLKILLLDGSDISDVGVSYLRLTVITSLVKLSLRGCKRLTDKCISALFDGTSKLQLQELDLSNLPHLSDNGILTLATCRVPISELRVRQCPLIGDTSVIALASMLVDDDRWYGSSIRLLDLYNCGGITQLAFRWLKKPYFPRLRWLGVTGSVNRDILDALARSRPFLNVACRGEELGVDQWDNSDGMYMHDYDEVDELEQWLMEG**********ANAEINAEPME
MQGSKALILMFDISLFLRHNFARVWALASEKLTSLEIGYISSVMVTELLSPNVEPHQSPNQIRPSILPGIQKLCLSVDYITDAMVGTISQGLVSLTHLDLRDAPLIEPRITFDLTNSGLQQINQHGKLKHLSLIRSQEFLITYFRRVNDLGILLMADKCASMESICLGGFCRVTDTGFKTILHSCSNLYKLRVSHGTQLTDLVFHDISATSLSLTHVCLRWCNLLTNHAIKSLASNTGIKVLDLRDCKNLGDEALRAISSLPQLKILLLDGSDISDVGVSYLRLTVITSLVKLSLRGCKRLTDKCISALFDGTSKLQLQELDLSNLPHLSDNGILTLATCRVPISELRVRQCPLIGDTSVIALASMLVDDDRWYGSSIRLLDLYNCGGITQLAFRWLKKPYFPRLRWLGVTGSVNRDILDALARSRPFLNVACRGEELGVDQWDNSDGMYMHDYDEVDELEQWLMEGE********************
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
SSSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MQGSKALILMFDISLFLRHNFARVWALASEKLTSLEIGYISSVMVTELLSPNVEPHQSPNQIRPSILPGIQKLCLSVDYITDAMVGTISQGLVSLTHLDLRDAPLIEPRITFDLTNSGLQQINQHGKLKHLSLIRSQEFLITYFRRVNDLGILLMADKCASMESICLGGFCRVTDTGFKTILHSCSNLYKLRVSHGTQLTDLVFHDISATSLSLTHVCLRWCNLLTNHAIKSLASNTGIKVLDLRDCKNLGDEALRAISSLPQLKILLLDGSDISDVGVSYLRLTVITSLVKLSLRGCKRLTDKCISALFDGTSKLQLQELDLSNLPHLSDNGILTLATCRVPISELRVRQCPLIGDTSVIALASMLVDDDRWYGSSIRLLDLYNCGGITQLAFRWLKKPYFPRLRWLGVTGSVNRDILDALARSRPFLNVACRGEELGVDQWDNSDGMYMHDYDEVDELEQWLMEGEDESDNDEEMANAEINAEPME
no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST ?

ID ?Alignment graph ?Length ? Definition ? RBH(Q2H) ? RBH(H2Q) ? Q cover ? H cover ? Identity ? E-value ?
Query488 2.2.26 [Sep-21-2011]
Q9SDA8656 F-box/LRR-repeat protein yes no 0.952 0.708 0.608 1e-159
Q9ZWC6607 F-box protein At-B OS=Ara no no 0.793 0.637 0.372 9e-63
Q9UKC9423 F-box/LRR-repeat protein yes no 0.510 0.588 0.286 1e-14
A1A5X2489 F-box/LRR-repeat protein yes no 0.514 0.513 0.266 1e-14
Q5R3Z8423 F-box/LRR-repeat protein yes no 0.510 0.588 0.286 2e-14
Q8BH16423 F-box/LRR-repeat protein yes no 0.440 0.508 0.298 1e-13
C8V4D4585 SCF E3 ubiquitin ligase c yes no 0.581 0.485 0.243 7e-13
A6H779423 F-box/LRR-repeat protein yes no 0.510 0.588 0.271 1e-12
Q5BJ29491 F-box/LRR-repeat protein no no 0.514 0.511 0.25 1e-12
Q9CZV8436 F-box/LRR-repeat protein no no 0.491 0.550 0.267 1e-11
>sp|Q9SDA8|FBL10_ARATH F-box/LRR-repeat protein 10 OS=Arabidopsis thaliana GN=FBL10 PE=2 SV=1 Back     alignment and function desciption
 Score =  561 bits (1447), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 286/470 (60%), Positives = 366/470 (77%), Gaps = 5/470 (1%)

Query: 5   KALILMFDISLFLRHNFARVWALASEKLTSLEIGYISSVMVTELLSPNVEPHQSPNQIRP 64
           + L LMFD+SL+LR    R++ L S++LT LE+G+I+S M+T+LL+      Q  N++  
Sbjct: 170 EVLALMFDLSLYLRPGDGRIFGLVSDRLTHLELGHITSRMMTQLLTSTEISGQDSNRVTT 229

Query: 65  S-ILPGIQKLCLSVDYITDAMVGTISQGLVSLTHLDLRDAPLIEPRITFDLTNSGLQQIN 123
           S +L  +Q+L LSVD ITDA+V  IS+ L SL  LD+RDAPL +PR   DLT+ GL +IN
Sbjct: 230 STVLQNVQRLRLSVDCITDAVVKAISKSLPSLIDLDIRDAPLEDPRQVSDLTDFGLHEIN 289

Query: 124 QHGKLKHLSLIRSQEFLITYFRRVNDLGILLMADKCASMESICLGGFCRVTDTGFKTILH 183
           Q+GKLKHLSLIRSQEF  TYFRRV+D G+L +ADKC  ME+ICLGGFCRVTD GFKTILH
Sbjct: 290 QNGKLKHLSLIRSQEFHPTYFRRVSDQGMLFLADKCLGMETICLGGFCRVTDAGFKTILH 349

Query: 184 SCSNLYKLRVSHGTQLTDLVFHDISATSLSLTHVCLRWCNLLTNHAIKSLASNTGIKVLD 243
           SC++L K  + HG +LTDLVFHDI AT+LSL+HV LR C+LLT+HAI+ LAS+  ++ LD
Sbjct: 350 SCASLSKFSIYHGPKLTDLVFHDILATTLSLSHVSLRRCHLLTDHAIQKLASSLKLENLD 409

Query: 244 LRDCKNLGDEALRAISSLPQLKILLLDGSDISDVGVSYLRLTVITSLVKLSLRGCKRLTD 303
           LR C+NL DE L A+S LP+LK+LLLDG+DISD G+SYL+  V+ SLV LS+RGC+ LTD
Sbjct: 410 LRGCRNLRDETLTAVSHLPKLKVLLLDGADISDTGLSYLKEGVLDSLVSLSVRGCRNLTD 469

Query: 304 KCISALFDGTSKLQLQELDLSNLPHLSDNGILTLATCRVPISELRVRQCPLIGDTSVIAL 363
           K +S LFDG+SKL L+ELDLSNLP+L+D  I  LA    PI++L++R+C LIGD SV+AL
Sbjct: 470 KFMSTLFDGSSKLALRELDLSNLPNLTDAAIFALAKSGAPITKLQLRECRLIGDASVMAL 529

Query: 364 ASMLVDDDRWYGSSIRLLDLYNCGGITQLAFRWLKKPYFPRLRWLGVTGSVNRDILDALA 423
           AS  V +D   GSS+ LLDLY+CGGITQL+F+WLKKP+FPRL+WLG+TGSVNRDI+DALA
Sbjct: 530 ASTRVYEDECPGSSLCLLDLYDCGGITQLSFKWLKKPFFPRLKWLGITGSVNRDIVDALA 589

Query: 424 RSRPFLNVACRGEELG---VDQWDNSDGMYMHDYDEVDELEQWLMEGEDE 470
           R RP L V+CRGEELG    D WD++D ++ H   + DELEQW++  E +
Sbjct: 590 RRRPHLQVSCRGEELGNDGEDDWDSAD-IHQHIEAQEDELEQWILGDEGD 638





Arabidopsis thaliana (taxid: 3702)
>sp|Q9ZWC6|ATB_ARATH F-box protein At-B OS=Arabidopsis thaliana GN=ATB PE=2 SV=1 Back     alignment and function description
>sp|Q9UKC9|FBXL2_HUMAN F-box/LRR-repeat protein 2 OS=Homo sapiens GN=FBXL2 PE=1 SV=3 Back     alignment and function description
>sp|A1A5X2|FBXL7_DANRE F-box/LRR-repeat protein 7 OS=Danio rerio GN=fbxl7 PE=2 SV=1 Back     alignment and function description
>sp|Q5R3Z8|FBXL2_PONAB F-box/LRR-repeat protein 2 OS=Pongo abelii GN=FBXL2 PE=2 SV=1 Back     alignment and function description
>sp|Q8BH16|FBXL2_MOUSE F-box/LRR-repeat protein 2 OS=Mus musculus GN=Fbxl2 PE=1 SV=1 Back     alignment and function description
>sp|C8V4D4|GRRA_EMENI SCF E3 ubiquitin ligase complex F-box protein grrA OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) GN=grrA PE=2 SV=1 Back     alignment and function description
>sp|A6H779|FBXL2_BOVIN F-box/LRR-repeat protein 2 OS=Bos taurus GN=FBXL2 PE=2 SV=1 Back     alignment and function description
>sp|Q5BJ29|FBXL7_MOUSE F-box/LRR-repeat protein 7 OS=Mus musculus GN=Fbxl7 PE=1 SV=1 Back     alignment and function description
>sp|Q9CZV8|FXL20_MOUSE F-box/LRR-repeat protein 20 OS=Mus musculus GN=Fbxl20 PE=1 SV=3 Back     alignment and function description

Close Homologs in the Non-Redundant Database Detected by BLAST ?

GI ?Alignment Graph ?Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query488
255577864 643 ubiquitin-protein ligase, putative [Rici 0.979 0.743 0.830 0.0
224080674 643 predicted protein [Populus trichocarpa] 0.922 0.699 0.829 0.0
356575440 637 PREDICTED: F-box/LRR-repeat protein 10-l 0.981 0.751 0.779 0.0
359474824 719 PREDICTED: F-box/LRR-repeat protein 10-l 0.942 0.639 0.794 0.0
224103131 644 f-box family protein [Populus trichocarp 0.928 0.703 0.825 0.0
357444831 643 F-box/LRR-repeat protein [Medicago trunc 0.989 0.751 0.772 0.0
359474995 640 PREDICTED: F-box/LRR-repeat protein 10-l 0.942 0.718 0.787 0.0
449454247 637 PREDICTED: F-box/LRR-repeat protein 10-l 0.944 0.723 0.722 0.0
449508806 637 PREDICTED: LOW QUALITY PROTEIN: F-box/LR 0.944 0.723 0.720 0.0
413956960 640 hypothetical protein ZEAMMB73_141308 [Ze 0.961 0.732 0.622 1e-166
>gi|255577864|ref|XP_002529805.1| ubiquitin-protein ligase, putative [Ricinus communis] gi|223530716|gb|EEF32587.1| ubiquitin-protein ligase, putative [Ricinus communis] Back     alignment and taxonomy information
 Score =  817 bits (2111), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 398/479 (83%), Positives = 442/479 (92%), Gaps = 1/479 (0%)

Query: 5   KALILMFDISLFLRHNFARVWALASEKLTSLEIGYISSVMVTELLSPNVEPHQSPNQIRP 64
           +AL LMFD+SLFLRHNF RVWALASEKLTSLEIGYISSVMVTELL+P+V PHQS N IRP
Sbjct: 163 EALTLMFDVSLFLRHNFTRVWALASEKLTSLEIGYISSVMVTELLTPSVGPHQSLNHIRP 222

Query: 65  SILPGIQKLCLSVDYITDAMVGTISQGLVSLTHLDLRDAPLIEPRITFDLTNSGLQQINQ 124
           SILPGIQKL LSVDYITD MVGTIS+GL+ LTHLDLRD PLIEPRITFDLTNSGLQQINQ
Sbjct: 223 SILPGIQKLSLSVDYITDTMVGTISKGLMFLTHLDLRDTPLIEPRITFDLTNSGLQQINQ 282

Query: 125 HGKLKHLSLIRSQEFLITYFRRVNDLGILLMADKCASMESICLGGFCRVTDTGFKTILHS 184
           +GKL+HLSL RSQEF+ITYFRRVNDLGILLMAD CASMESICLGGFC+VTDTGFKTILHS
Sbjct: 283 YGKLRHLSLFRSQEFVITYFRRVNDLGILLMADNCASMESICLGGFCQVTDTGFKTILHS 342

Query: 185 CSNLYKLRVSHGTQLTDLVFHDISATSLSLTHVCLRWCNLLTNHAIKSLASNTGIKVLDL 244
           CS+L++LRVS G  LTDLVFHD+SATSL L+HVCLRWCNLLTN+AIK+L +NT +KVLDL
Sbjct: 343 CSSLHRLRVSRGIHLTDLVFHDMSATSLCLSHVCLRWCNLLTNYAIKNLVANTHLKVLDL 402

Query: 245 RDCKNLGDEALRAISSLPQLKILLLDGSDISDVGVSYLRLTVITSLVKLSLRGCKRLTDK 304
           RDCKNLGDE+LRAIS+L +LKILLLDGS ISD G+S LR  VI+SLV LS+RGCKRLTDK
Sbjct: 403 RDCKNLGDESLRAISTLFELKILLLDGSGISDSGLSNLRGRVISSLVSLSVRGCKRLTDK 462

Query: 305 CISALFDGTSKLQLQELDLSNLPHLSDNGILTLATCRVPISELRVRQCPLIGDTSVIALA 364
           CISALF+G SKL+LQELD+SNLP+LSDNGIL LA  R+PIS LR+RQCPLIGDTSV+ALA
Sbjct: 463 CISALFEGASKLELQELDISNLPNLSDNGILCLAKSRLPISALRMRQCPLIGDTSVMALA 522

Query: 365 SMLVDDDRWYGSSIRLLDLYNCGGITQLAFRWLKKPYFPRLRWLGVTGSVNRDILDALAR 424
           SM VD+DR +GSS+RLLD+YNCGGITQLAFRWLKKPYFPRLRWLGVTGSVNRDI+DALAR
Sbjct: 523 SMQVDEDRGHGSSLRLLDIYNCGGITQLAFRWLKKPYFPRLRWLGVTGSVNRDIIDALAR 582

Query: 425 SRPFLNVACRGEELGVDQWDNSDGMYMHDYDEVDELEQWLMEGEDESDNDEEMANAEIN 483
           +RPFL+VAC  EELG+DQWDNSD +YMHDYDEVDELEQWL+EGE E +NDEEM +AEIN
Sbjct: 583 NRPFLHVACHAEELGIDQWDNSDSLYMHDYDEVDELEQWLLEGEFE-NNDEEMVDAEIN 640




Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Class:

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224080674|ref|XP_002306206.1| predicted protein [Populus trichocarpa] gi|222849170|gb|EEE86717.1| predicted protein [Populus trichocarpa] Back     alignment and taxonomy information
>gi|356575440|ref|XP_003555849.1| PREDICTED: F-box/LRR-repeat protein 10-like [Glycine max] Back     alignment and taxonomy information
>gi|359474824|ref|XP_003631537.1| PREDICTED: F-box/LRR-repeat protein 10-like [Vitis vinifera] Back     alignment and taxonomy information
>gi|224103131|ref|XP_002312937.1| f-box family protein [Populus trichocarpa] gi|222849345|gb|EEE86892.1| f-box family protein [Populus trichocarpa] Back     alignment and taxonomy information
>gi|357444831|ref|XP_003592693.1| F-box/LRR-repeat protein [Medicago truncatula] gi|358345302|ref|XP_003636720.1| F-box/LRR-repeat protein [Medicago truncatula] gi|355481741|gb|AES62944.1| F-box/LRR-repeat protein [Medicago truncatula] gi|355502655|gb|AES83858.1| F-box/LRR-repeat protein [Medicago truncatula] Back     alignment and taxonomy information
>gi|359474995|ref|XP_003631565.1| PREDICTED: F-box/LRR-repeat protein 10-like [Vitis vinifera] Back     alignment and taxonomy information
>gi|449454247|ref|XP_004144867.1| PREDICTED: F-box/LRR-repeat protein 10-like [Cucumis sativus] Back     alignment and taxonomy information
>gi|449508806|ref|XP_004163416.1| PREDICTED: LOW QUALITY PROTEIN: F-box/LRR-repeat protein 10-like [Cucumis sativus] Back     alignment and taxonomy information
>gi|413956960|gb|AFW89609.1| hypothetical protein ZEAMMB73_141308 [Zea mays] Back     alignment and taxonomy information

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST ?

ID ? Alignment graph ? Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query488
TAIR|locus:2827644656 AT2G17020 "AT2G17020" [Arabido 0.975 0.725 0.603 7.9e-149
TAIR|locus:2020477607 AT1G55590 [Arabidopsis thalian 0.795 0.639 0.378 4.8e-62
RGD|1562243422 Fbxl2 "F-box and leucine-rich 0.438 0.507 0.315 6.3e-17
MGI|MGI:1919429423 Fbxl2 "F-box and leucine-rich 0.438 0.505 0.310 8.3e-17
UNIPROTKB|Q9UKC9423 FBXL2 "F-box/LRR-repeat protei 0.438 0.505 0.315 8.3e-17
UNIPROTKB|Q5R3Z8423 FBXL2 "F-box/LRR-repeat protei 0.438 0.505 0.315 8.3e-17
UNIPROTKB|F1PWK1422 FBXL2 "Uncharacterized protein 0.438 0.507 0.310 1.4e-16
UNIPROTKB|F1NHD2423 FBXL2 "Uncharacterized protein 0.438 0.505 0.301 1.4e-16
ASPGD|ASPL0000017608585 grrA [Emericella nidulans (tax 0.778 0.649 0.246 2.1e-15
UNIPROTKB|A6H779423 FBXL2 "F-box/LRR-repeat protei 0.438 0.505 0.297 7.2e-15
TAIR|locus:2827644 AT2G17020 "AT2G17020" [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
 Score = 1453 (516.5 bits), Expect = 7.9e-149, P = 7.9e-149
 Identities = 294/487 (60%), Positives = 374/487 (76%)

Query:     5 KALILMFDISLFLRHNFARVWALASEKLTSLEIGYISSVMVTELLSPNVEPHQSPNQIRP 64
             + L LMFD+SL+LR    R++ L S++LT LE+G+I+S M+T+LL+      Q  N++  
Sbjct:   170 EVLALMFDLSLYLRPGDGRIFGLVSDRLTHLELGHITSRMMTQLLTSTEISGQDSNRVTT 229

Query:    65 S-ILPGIQKLCLSVDYITDAMVGTISQGLVSLTHLDLRDAPLIEPRITFDLTNSGLQQIN 123
             S +L  +Q+L LSVD ITDA+V  IS+ L SL  LD+RDAPL +PR   DLT+ GL +IN
Sbjct:   230 STVLQNVQRLRLSVDCITDAVVKAISKSLPSLIDLDIRDAPLEDPRQVSDLTDFGLHEIN 289

Query:   124 QHGKLKHLSLIRSQEFLITYFRRVNDLGILLMADKCASMESICLGGFCRVTDTGFKTILH 183
             Q+GKLKHLSLIRSQEF  TYFRRV+D G+L +ADKC  ME+ICLGGFCRVTD GFKTILH
Sbjct:   290 QNGKLKHLSLIRSQEFHPTYFRRVSDQGMLFLADKCLGMETICLGGFCRVTDAGFKTILH 349

Query:   184 SCSNLYKLRVSHGTQLTDLVFHDISATSLSLTHVCLRWCNLLTNHAIKSLASNTGIKVLD 243
             SC++L K  + HG +LTDLVFHDI AT+LSL+HV LR C+LLT+HAI+ LAS+  ++ LD
Sbjct:   350 SCASLSKFSIYHGPKLTDLVFHDILATTLSLSHVSLRRCHLLTDHAIQKLASSLKLENLD 409

Query:   244 LRDCKNLGDEALRAISSLPQLKILLLDGSDISDVGVSYLRLTVITSLVKLSLRGCKRLTD 303
             LR C+NL DE L A+S LP+LK+LLLDG+DISD G+SYL+  V+ SLV LS+RGC+ LTD
Sbjct:   410 LRGCRNLRDETLTAVSHLPKLKVLLLDGADISDTGLSYLKEGVLDSLVSLSVRGCRNLTD 469

Query:   304 KCISALFDGTSKLQLQELDLSNLPHLSDNGILTLATCRVPISELRVRQCPLIGDTSVIAL 363
             K +S LFDG+SKL L+ELDLSNLP+L+D  I  LA    PI++L++R+C LIGD SV+AL
Sbjct:   470 KFMSTLFDGSSKLALRELDLSNLPNLTDAAIFALAKSGAPITKLQLRECRLIGDASVMAL 529

Query:   364 ASMLVDDDRWYGSSIRLLDLYNCGGITQLAFRWLKKPYFPRLRWLGVTGSVNRDILDALA 423
             AS  V +D   GSS+ LLDLY+CGGITQL+F+WLKKP+FPRL+WLG+TGSVNRDI+DALA
Sbjct:   530 ASTRVYEDECPGSSLCLLDLYDCGGITQLSFKWLKKPFFPRLKWLGITGSVNRDIVDALA 589

Query:   424 RSRPFLNVACRGEELG---VDQWDNSDGMYMHDYDEVDELEQWLM--EG----EDESDND 474
             R RP L V+CRGEELG    D WD++D ++ H   + DELEQW++  EG    ED  D  
Sbjct:   590 RRRPHLQVSCRGEELGNDGEDDWDSAD-IHQHIEAQEDELEQWILGDEGDVEMEDAEDES 648

Query:   475 EEMANAE 481
             EE A+ E
Sbjct:   649 EEDASEE 655




GO:0004842 "ubiquitin-protein ligase activity" evidence=ISS
GO:0005737 "cytoplasm" evidence=ISM
GO:0006511 "ubiquitin-dependent protein catabolic process" evidence=TAS
GO:0006486 "protein glycosylation" evidence=RCA
TAIR|locus:2020477 AT1G55590 [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
RGD|1562243 Fbxl2 "F-box and leucine-rich repeat protein 2" [Rattus norvegicus (taxid:10116)] Back     alignment and assigned GO terms
MGI|MGI:1919429 Fbxl2 "F-box and leucine-rich repeat protein 2" [Mus musculus (taxid:10090)] Back     alignment and assigned GO terms
UNIPROTKB|Q9UKC9 FBXL2 "F-box/LRR-repeat protein 2" [Homo sapiens (taxid:9606)] Back     alignment and assigned GO terms
UNIPROTKB|Q5R3Z8 FBXL2 "F-box/LRR-repeat protein 2" [Pongo abelii (taxid:9601)] Back     alignment and assigned GO terms
UNIPROTKB|F1PWK1 FBXL2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] Back     alignment and assigned GO terms
UNIPROTKB|F1NHD2 FBXL2 "Uncharacterized protein" [Gallus gallus (taxid:9031)] Back     alignment and assigned GO terms
ASPGD|ASPL0000017608 grrA [Emericella nidulans (taxid:162425)] Back     alignment and assigned GO terms
UNIPROTKB|A6H779 FBXL2 "F-box/LRR-repeat protein 2" [Bos taurus (taxid:9913)] Back     alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries ?

ID ?Name ?Annotated EC number ?Identity ?Query coverage ?Hit coverage ?RBH(Q2H) ?RBH(H2Q) ?
Q9SDA8FBL10_ARATHNo assigned EC number0.60850.95280.7088yesno

EC Number Prediction by Ezypred Server ?

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software ?

No EC number assignment, probably not an enzyme!


Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING ?

Fail to connect to STRING server


Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query488
cd09293226 cd09293, AMN1, Antagonist of mitotic exit network 8e-11
cd09293226 cd09293, AMN1, Antagonist of mitotic exit network 4e-06
cd09293226 cd09293, AMN1, Antagonist of mitotic exit network 1e-04
cd09293226 cd09293, AMN1, Antagonist of mitotic exit network 0.001
cd00116319 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo 0.001
>gnl|CDD|187754 cd09293, AMN1, Antagonist of mitotic exit network protein 1 Back     alignment and domain information
 Score = 61.6 bits (150), Expect = 8e-11
 Identities = 36/124 (29%), Positives = 61/124 (49%), Gaps = 5/124 (4%)

Query: 213 SLTHVCLRWCNLLTNHAIKSLASN-TGIKVLDL---RDCKNLGDEALRAISSL-PQLKIL 267
           +L  + LR C  +T+  I +LA+N   ++ ++L   R+   + D +L A+      L+ +
Sbjct: 79  NLQVLDLRACENITDSGIVALATNCPKLQTINLGRHRNGHLITDVSLSALGKNCTFLQTV 138

Query: 268 LLDGSDISDVGVSYLRLTVITSLVKLSLRGCKRLTDKCISALFDGTSKLQLQELDLSNLP 327
              G D++D GV  L      SL +LSL  C+ LTD+ I A+        L  L+    P
Sbjct: 139 GFAGCDVTDKGVWELASGCSKSLERLSLNNCRNLTDQSIPAILASNYFPNLSVLEFRGCP 198

Query: 328 HLSD 331
            ++D
Sbjct: 199 LITD 202


Amn1 has been functionally characterized in Saccharomyces cerevisiae as a component of the Antagonist of MEN pathway (AMEN). The AMEN network is activated by MEN (mitotic exit network) via an active Cdc14, and in turn switches off MEN. Amn1 constitutes one of the alternative mechanisms by which MEN may be disrupted. Specifically, Amn1 binds Tem1 (Termination of M-phase, a GTPase that belongs to the RAS superfamily), and disrupts its association with Cdc15, the primary downstream target. Amn1 is a leucine-rich repeat (LRR) protein, with 12 repeats in the S. cerevisiae ortholog. As a negative regulator of the signal transduction pathway MEN, overexpression of AMN1 slows the growth of wild type cells. The function of the vertebrate members of this family has not been determined experimentally, they have fewer LRRs that determine the extent of this model. Length = 226

>gnl|CDD|187754 cd09293, AMN1, Antagonist of mitotic exit network protein 1 Back     alignment and domain information
>gnl|CDD|187754 cd09293, AMN1, Antagonist of mitotic exit network protein 1 Back     alignment and domain information
>gnl|CDD|187754 cd09293, AMN1, Antagonist of mitotic exit network protein 1 Back     alignment and domain information
>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information

Conserved Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query 488
KOG4341483 consensus F-box protein containing LRR [General fu 99.96
KOG4341483 consensus F-box protein containing LRR [General fu 99.95
KOG4194 873 consensus Membrane glycoprotein LIG-1 [Signal tran 99.84
PLN00113 968 leucine-rich repeat receptor-like protein kinase; 99.82
PLN00113 968 leucine-rich repeat receptor-like protein kinase; 99.79
cd00116319 LRR_RI Leucine-rich repeats (LRRs), ribonuclease i 99.75
KOG4194 873 consensus Membrane glycoprotein LIG-1 [Signal tran 99.74
KOG2120419 consensus SCF ubiquitin ligase, Skp2 component [Po 99.73
PLN03210 1153 Resistant to P. syringae 6; Provisional 99.67
cd00116319 LRR_RI Leucine-rich repeats (LRRs), ribonuclease i 99.66
KOG2120419 consensus SCF ubiquitin ligase, Skp2 component [Po 99.64
KOG1909382 consensus Ran GTPase-activating protein [RNA proce 99.6
KOG1947482 consensus Leucine rich repeat proteins, some prote 99.53
KOG1909382 consensus Ran GTPase-activating protein [RNA proce 99.52
KOG0444 1255 consensus Cytoskeletal regulator Flightless-I (con 99.52
KOG1947482 consensus Leucine rich repeat proteins, some prote 99.44
PLN03210 1153 Resistant to P. syringae 6; Provisional 99.43
KOG0444 1255 consensus Cytoskeletal regulator Flightless-I (con 99.36
COG5238388 RNA1 Ran GTPase-activating protein (RanGAP) involv 99.16
KOG3207505 consensus Beta-tubulin folding cofactor E [Posttra 99.13
KOG0618 1081 consensus Serine/threonine phosphatase 2C containi 99.08
KOG3207505 consensus Beta-tubulin folding cofactor E [Posttra 99.07
KOG0618 1081 consensus Serine/threonine phosphatase 2C containi 98.89
COG5238388 RNA1 Ran GTPase-activating protein (RanGAP) involv 98.87
PRK15387 788 E3 ubiquitin-protein ligase SspH2; Provisional 98.84
KOG3665 699 consensus ZYG-1-like serine/threonine protein kina 98.83
PRK15387 788 E3 ubiquitin-protein ligase SspH2; Provisional 98.81
KOG3665 699 consensus ZYG-1-like serine/threonine protein kina 98.81
KOG4237498 consensus Extracellular matrix protein slit, conta 98.63
KOG2982418 consensus Uncharacterized conserved protein [Funct 98.48
KOG4237498 consensus Extracellular matrix protein slit, conta 98.47
PRK15370 754 E3 ubiquitin-protein ligase SlrP; Provisional 98.46
KOG2982418 consensus Uncharacterized conserved protein [Funct 98.45
KOG0472565 consensus Leucine-rich repeat protein [Function un 98.41
PF14580175 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ 98.4
KOG0472565 consensus Leucine-rich repeat protein [Function un 98.38
KOG3864221 consensus Uncharacterized conserved protein [Funct 98.37
PRK15370 754 E3 ubiquitin-protein ligase SlrP; Provisional 98.36
KOG1259490 consensus Nischarin, modulator of integrin alpha5 98.33
PF14580175 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ 98.18
KOG3864221 consensus Uncharacterized conserved protein [Funct 98.16
KOG4658889 consensus Apoptotic ATPase [Signal transduction me 98.12
KOG1259490 consensus Nischarin, modulator of integrin alpha5 97.94
KOG4658889 consensus Apoptotic ATPase [Signal transduction me 97.85
PF1385561 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF 97.53
KOG0617264 consensus Ras suppressor protein (contains leucine 97.49
PF1385561 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF 97.46
KOG1859 1096 consensus Leucine-rich repeat proteins [General fu 97.45
KOG4308478 consensus LRR-containing protein [Function unknown 97.4
KOG1859 1096 consensus Leucine-rich repeat proteins [General fu 97.17
KOG0617264 consensus Ras suppressor protein (contains leucine 97.03
PRK15386426 type III secretion protein GogB; Provisional 96.94
KOG4308478 consensus LRR-containing protein [Function unknown 96.92
KOG2739260 consensus Leucine-rich acidic nuclear protein [Cel 96.81
smart0036726 LRR_CC Leucine-rich repeat - CC (cysteine-containi 96.75
KOG2739260 consensus Leucine-rich acidic nuclear protein [Cel 96.55
PLN03150623 hypothetical protein; Provisional 96.47
smart0036726 LRR_CC Leucine-rich repeat - CC (cysteine-containi 96.47
KOG2123388 consensus Uncharacterized conserved protein [Funct 96.25
PLN03150623 hypothetical protein; Provisional 96.24
PRK15386 426 type III secretion protein GogB; Provisional 96.18
PF1279944 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ 95.98
PF1279944 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ 95.69
KOG2123 388 consensus Uncharacterized conserved protein [Funct 95.61
COG4886394 Leucine-rich repeat (LRR) protein [Function unknow 95.52
COG4886394 Leucine-rich repeat (LRR) protein [Function unknow 95.36
KOG1644233 consensus U2-associated snRNP A' protein [RNA proc 95.22
PF1351624 LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RI 94.26
KOG4579177 consensus Leucine-rich repeat (LRR) protein associ 93.74
PF1351624 LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RI 93.71
KOG1644233 consensus U2-associated snRNP A' protein [RNA proc 93.4
KOG0531414 consensus Protein phosphatase 1, regulatory subuni 93.04
KOG0531 414 consensus Protein phosphatase 1, regulatory subuni 91.56
KOG4579177 consensus Leucine-rich repeat (LRR) protein associ 91.54
smart0036828 LRR_RI Leucine rich repeat, ribonuclease inhibitor 88.65
KOG0532 722 consensus Leucine-rich repeat (LRR) protein, conta 86.15
smart0036828 LRR_RI Leucine rich repeat, ribonuclease inhibitor 85.67
KOG3763 585 consensus mRNA export factor TAP/MEX67 [RNA proces 84.25
KOG0532 722 consensus Leucine-rich repeat (LRR) protein, conta 82.45
PF13306129 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_ 81.43
PF1350417 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OO 80.03
>KOG4341 consensus F-box protein containing LRR [General function prediction only] Back     alignment and domain information
Probab=99.96  E-value=2.4e-29  Score=225.81  Aligned_cols=378  Identities=21%  Similarity=0.273  Sum_probs=295.5

Q ss_pred             HhhhccceeeeccccccccceecCCCCCCCCCCCcccCCCCCCCcEEEee--cCccChhHHHHHHhcC-CCccEEeccCC
Q 011317           27 LASEKLTSLEIGYISSVMVTELLSPNVEPHQSPNQIRPSILPGIQKLCLS--VDYITDAMVGTISQGL-VSLTHLDLRDA  103 (488)
Q Consensus        27 ~lp~~l~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~--~~~~~~~~~~~~~~~~-~~L~~L~L~~~  103 (488)
                      .+|+++....++++..|.+.+-..++..    |+-...- ..+-++.++.  ...+...++..+.+.+ ..|+.|.++||
T Consensus        74 ~LPpEl~lkvFS~LDtksl~r~a~~c~~----~n~~AlD-~~~~q~idL~t~~rDv~g~VV~~~~~Rcgg~lk~LSlrG~  148 (483)
T KOG4341|consen   74 SLPPELLLKVFSMLDTKSLCRAAQCCTM----WNKLALD-GSCWQHIDLFTFQRDVDGGVVENMISRCGGFLKELSLRGC  148 (483)
T ss_pred             cCCHHHHHHHHHHHhHHHHHHHHHHHHH----hhhhhhc-cccceeeehhcchhcCCCcceehHhhhhcccccccccccc
Confidence            4677888888888877766555443321    1110000 2233444444  1334445566666655 46889999988


Q ss_pred             CCCCCccccccChHHHHhhh-cCCCccEEEcccccccccccccccChHHHHHHHHhCCCCCEEEEcCCCCCCHHHHHHHH
Q 011317          104 PLIEPRITFDLTNSGLQQIN-QHGKLKHLSLIRSQEFLITYFRRVNDLGILLMADKCASMESICLGGFCRVTDTGFKTIL  182 (488)
Q Consensus       104 ~~~~~~~~~~~~~~~l~~l~-~~~~L~~L~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~l~~~~~~~~~~~~~~~  182 (488)
                      .        .+.+..+..+. .||++++|.+.        ++..+++..+..+...|++|++|++..|..+++..++.+.
T Consensus       149 r--------~v~~sslrt~~~~CpnIehL~l~--------gc~~iTd~s~~sla~~C~~l~~l~L~~c~~iT~~~Lk~la  212 (483)
T KOG4341|consen  149 R--------AVGDSSLRTFASNCPNIEHLALY--------GCKKITDSSLLSLARYCRKLRHLNLHSCSSITDVSLKYLA  212 (483)
T ss_pred             c--------cCCcchhhHHhhhCCchhhhhhh--------cceeccHHHHHHHHHhcchhhhhhhcccchhHHHHHHHHH
Confidence            4        45555666554 78999999884        4668888888888899999999999999899988888888


Q ss_pred             HhCCCCceEEecCCCCCCHHHHHHHHhcCCCCCEEEecCCCCCCHHHHHHhh-CCCCcCEEeccCCCCCChHHHHhhc-C
Q 011317          183 HSCSNLYKLRVSHGTQLTDLVFHDISATSLSLTHVCLRWCNLLTNHAIKSLA-SNTGIKVLDLRDCKNLGDEALRAIS-S  260 (488)
Q Consensus       183 ~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~l~-~~~~L~~L~l~~~~~~~~~~~~~l~-~  260 (488)
                      +.|++|++|++++|+.+...++..+.+.+..++.+...+|...+...+.... .++-+..+++..|..+++..+..+. .
T Consensus       213 ~gC~kL~~lNlSwc~qi~~~gv~~~~rG~~~l~~~~~kGC~e~~le~l~~~~~~~~~i~~lnl~~c~~lTD~~~~~i~~~  292 (483)
T KOG4341|consen  213 EGCRKLKYLNLSWCPQISGNGVQALQRGCKELEKLSLKGCLELELEALLKAAAYCLEILKLNLQHCNQLTDEDLWLIACG  292 (483)
T ss_pred             HhhhhHHHhhhccCchhhcCcchHHhccchhhhhhhhcccccccHHHHHHHhccChHhhccchhhhccccchHHHHHhhh
Confidence            8999999999999988888888888888888888888888887777666554 5677778888888888888866665 6


Q ss_pred             CCCccEEEeCCC-ccchhHHHHHHhhcCCCccEEecCCCCCCCHHHHHHHhccCCCCCeeEEecCCCCCCCHHHHHHHHh
Q 011317          261 LPQLKILLLDGS-DISDVGVSYLRLTVITSLVKLSLRGCKRLTDKCISALFDGTSKLQLQELDLSNLPHLSDNGILTLAT  339 (488)
Q Consensus       261 ~~~L~~L~l~~~-~i~~~~~~~l~~~~~~~L~~L~l~~~~~l~~~~~~~l~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~  339 (488)
                      +..|+.|..++| .+++..+..+.+ ++++|+.|.+.+|..+++.++..+.++|  +.|+.+++.+|-.+++..+..++.
T Consensus       293 c~~lq~l~~s~~t~~~d~~l~aLg~-~~~~L~~l~l~~c~~fsd~~ft~l~rn~--~~Le~l~~e~~~~~~d~tL~sls~  369 (483)
T KOG4341|consen  293 CHALQVLCYSSCTDITDEVLWALGQ-HCHNLQVLELSGCQQFSDRGFTMLGRNC--PHLERLDLEECGLITDGTLASLSR  369 (483)
T ss_pred             hhHhhhhcccCCCCCchHHHHHHhc-CCCceEEEeccccchhhhhhhhhhhcCC--hhhhhhcccccceehhhhHhhhcc
Confidence            788999999887 788888888888 8899999999999999999999998888  899999999988888888888888


Q ss_pred             cCCCCCeEeecCCCCCCHHHHHHHHcccccCCCCCCCCccEEeccCCCCCCHHHHHHhhccCCCCccEEEecCCC--CHH
Q 011317          340 CRVPISELRVRQCPLIGDTSVIALASMLVDDDRWYGSSIRLLDLYNCGGITQLAFRWLKKPYFPRLRWLGVTGSV--NRD  417 (488)
Q Consensus       340 ~~~~L~~L~l~~~~~l~~~~~~~l~~~~~~~~~~~~~~L~~L~l~~~~~i~~~~~~~l~~~~~~~L~~L~l~~~~--~~~  417 (488)
                      +|+.|+.|.+++|..++|.|+..+.....     ....|+.+.+++|+.+++..+.++..  |++|+.+++.+|.  ...
T Consensus       370 ~C~~lr~lslshce~itD~gi~~l~~~~c-----~~~~l~~lEL~n~p~i~d~~Le~l~~--c~~Leri~l~~~q~vtk~  442 (483)
T KOG4341|consen  370 NCPRLRVLSLSHCELITDEGIRHLSSSSC-----SLEGLEVLELDNCPLITDATLEHLSI--CRNLERIELIDCQDVTKE  442 (483)
T ss_pred             CCchhccCChhhhhhhhhhhhhhhhhccc-----cccccceeeecCCCCchHHHHHHHhh--Ccccceeeeechhhhhhh
Confidence            99999999999998899998888765332     56789999999999999999988876  9999999999885  577


Q ss_pred             HHHHHHhhCCCceeeccc
Q 011317          418 ILDALARSRPFLNVACRG  435 (488)
Q Consensus       418 ~~~~~~~~~~~l~~~~~~  435 (488)
                      .+..+....|.+++--..
T Consensus       443 ~i~~~~~~lp~i~v~a~~  460 (483)
T KOG4341|consen  443 AISRFATHLPNIKVHAYF  460 (483)
T ss_pred             hhHHHHhhCccceehhhc
Confidence            888888999988775443



>KOG4341 consensus F-box protein containing LRR [General function prediction only] Back     alignment and domain information
>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] Back     alignment and domain information
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional Back     alignment and domain information
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional Back     alignment and domain information
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] Back     alignment and domain information
>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>PLN03210 Resistant to P Back     alignment and domain information
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] Back     alignment and domain information
>KOG1947 consensus Leucine rich repeat proteins, some proteins contain F-box [General function prediction only] Back     alignment and domain information
>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] Back     alignment and domain information
>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] Back     alignment and domain information
>KOG1947 consensus Leucine rich repeat proteins, some proteins contain F-box [General function prediction only] Back     alignment and domain information
>PLN03210 Resistant to P Back     alignment and domain information
>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] Back     alignment and domain information
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information
>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] Back     alignment and domain information
>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] Back     alignment and domain information
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional Back     alignment and domain information
>KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] Back     alignment and domain information
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional Back     alignment and domain information
>KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] Back     alignment and domain information
>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] Back     alignment and domain information
>KOG2982 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] Back     alignment and domain information
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional Back     alignment and domain information
>KOG2982 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG0472 consensus Leucine-rich repeat protein [Function unknown] Back     alignment and domain information
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A Back     alignment and domain information
>KOG0472 consensus Leucine-rich repeat protein [Function unknown] Back     alignment and domain information
>KOG3864 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional Back     alignment and domain information
>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] Back     alignment and domain information
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A Back     alignment and domain information
>KOG3864 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] Back     alignment and domain information
>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] Back     alignment and domain information
>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] Back     alignment and domain information
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A Back     alignment and domain information
>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] Back     alignment and domain information
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A Back     alignment and domain information
>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] Back     alignment and domain information
>KOG4308 consensus LRR-containing protein [Function unknown] Back     alignment and domain information
>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] Back     alignment and domain information
>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] Back     alignment and domain information
>PRK15386 type III secretion protein GogB; Provisional Back     alignment and domain information
>KOG4308 consensus LRR-containing protein [Function unknown] Back     alignment and domain information
>KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] Back     alignment and domain information
>smart00367 LRR_CC Leucine-rich repeat - CC (cysteine-containing) subfamily Back     alignment and domain information
>KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] Back     alignment and domain information
>PLN03150 hypothetical protein; Provisional Back     alignment and domain information
>smart00367 LRR_CC Leucine-rich repeat - CC (cysteine-containing) subfamily Back     alignment and domain information
>KOG2123 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>PLN03150 hypothetical protein; Provisional Back     alignment and domain information
>PRK15386 type III secretion protein GogB; Provisional Back     alignment and domain information
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B Back     alignment and domain information
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B Back     alignment and domain information
>KOG2123 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown] Back     alignment and domain information
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown] Back     alignment and domain information
>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] Back     alignment and domain information
>PF13516 LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1DFJ_I 2BNH_A 3VQ1_A 3VQ2_A 2Z64_A 2OMX_A Back     alignment and domain information
>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] Back     alignment and domain information
>PF13516 LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1DFJ_I 2BNH_A 3VQ1_A 3VQ2_A 2Z64_A 2OMX_A Back     alignment and domain information
>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] Back     alignment and domain information
>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] Back     alignment and domain information
>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] Back     alignment and domain information
>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] Back     alignment and domain information
>smart00368 LRR_RI Leucine rich repeat, ribonuclease inhibitor type Back     alignment and domain information
>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] Back     alignment and domain information
>smart00368 LRR_RI Leucine rich repeat, ribonuclease inhibitor type Back     alignment and domain information
>KOG3763 consensus mRNA export factor TAP/MEX67 [RNA processing and modification] Back     alignment and domain information
>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] Back     alignment and domain information
>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A Back     alignment and domain information
>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D Back     alignment and domain information

Homologous Structure Templates

Structure Templates Detected by BLAST ?

No homologous structure with e-value below 0.005

Structure Templates Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query488
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 6e-30
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 3e-25
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 2e-24
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 3e-20
3ogk_B 592 Coronatine-insensitive protein 1; leucine rich rep 2e-13
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 1e-05
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 4e-28
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 3e-26
2p1m_B 594 Transport inhibitor response 1 protein; F-BOX, leu 4e-21
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 5e-27
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 8e-25
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 9e-14
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 1e-17
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 1e-16
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 4e-16
1z7x_W 461 Ribonuclease inhibitor; leucine-rich repeat, enzym 1e-14
1z7x_W 461 Ribonuclease inhibitor; leucine-rich repeat, enzym 9e-10
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 8e-14
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 5e-13
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 6e-12
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 7e-07
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 1e-12
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 1e-10
3e4g_A176 ATP synthase subunit S, mitochondrial; leucine-ric 2e-12
3e4g_A176 ATP synthase subunit S, mitochondrial; leucine-ric 5e-11
3e4g_A176 ATP synthase subunit S, mitochondrial; leucine-ric 2e-10
3e4g_A176 ATP synthase subunit S, mitochondrial; leucine-ric 7e-05
3e4g_A176 ATP synthase subunit S, mitochondrial; leucine-ric 2e-04
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 1e-11
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 9e-11
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 3e-10
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 9e-07
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 1e-08
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 2e-08
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 1e-07
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 3e-08
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 3e-06
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 5e-06
4ezg_A197 Putative uncharacterized protein; internalin-A, le 5e-08
4ezg_A197 Putative uncharacterized protein; internalin-A, le 5e-07
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 5e-06
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 8e-05
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 2e-04
4ecn_A 876 Leucine-rich repeat protein; leucine-rich repeats, 5e-06
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 4e-04
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 1e-05
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 1e-05
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 2e-04
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 3e-04
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 2e-05
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 6e-05
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 3e-05
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 9e-05
3t6q_A 606 CD180 antigen; protein-protein complex, leucine ri 1e-04
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 3e-05
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 6e-05
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 6e-05
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 8e-04
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 6e-05
3vq2_A 606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 7e-05
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 9e-05
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 8e-05
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 1e-04
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 1e-04
4fmz_A347 Internalin; leucine rich repeat, structural genomi 2e-04
4fmz_A347 Internalin; leucine rich repeat, structural genomi 8e-04
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 3e-04
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 4e-04
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 4e-04
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 6e-04
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 6e-04
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 Back     alignment and structure
 Score =  121 bits (306), Expect = 6e-30
 Identities = 56/323 (17%), Positives = 107/323 (33%), Gaps = 45/323 (13%)

Query: 67  LPGIQKLC-LSVDYITDAMVGTISQGLVSLTHLDLRDAPLIEPRITFDLTNSGLQQINQH 125
           L   +KLC L + Y+    +  +      +  LDL  A L         T      I + 
Sbjct: 266 LVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLE--------TEDHCTLIQKC 317

Query: 126 GKLKHLSLIRSQEFLITYFRRVNDLGILLMADKCASMESICLGGFC----------RVTD 175
             L+ L               + D G+ ++A  C  ++ + +               V+ 
Sbjct: 318 PNLEVLETRNV----------IGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQ 367

Query: 176 TGFKTILHSCSNLYKLRVSHGTQLTDLVFHDISATSLSLTHV-------CLRWCNLLTNH 228
            G   +   C  L  + V + + +T+     I     +L            R  +L  ++
Sbjct: 368 RGLIALAQGCQELEYMAV-YVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDN 426

Query: 229 AIKSLASN-TGIKVLDLR-DCKNLGDEALRAISSL-PQLKILLLDGSDISDVGVSYLRLT 285
            ++SL      ++          L D  L  I    P ++ +LL     SD G+      
Sbjct: 427 GVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEF-SR 485

Query: 286 VITSLVKLSLRGCKRLTDKCISALFDGTSKLQLQELDLSNLP-HLSDNGILTLATCRVPI 344
              +L KL +RGC   +++ I+A         L+ L +      ++   ++ +A     I
Sbjct: 486 GCPNLQKLEMRGC-CFSERAIAAAVTKLPS--LRYLWVQGYRASMTGQDLMQMARPYWNI 542

Query: 345 SELRVRQCPLIGDTSVIALASML 367
             +  R+ P +     I      
Sbjct: 543 ELIPSRRVPEVNQQGEIREMEHP 565


>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 Back     alignment and structure
>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Length = 176 Back     alignment and structure
>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Length = 176 Back     alignment and structure
>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Length = 176 Back     alignment and structure
>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Length = 176 Back     alignment and structure
>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Length = 176 Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure

Structure Templates Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query488
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 99.97
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 99.96
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 99.95
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 99.95
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 99.95
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 99.94
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 99.89
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 99.88
4fmz_A347 Internalin; leucine rich repeat, structural genomi 99.88
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 99.84
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 99.84
4fmz_A347 Internalin; leucine rich repeat, structural genomi 99.83
1o6v_A466 Internalin A; bacterial infection, extracellular r 99.82
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 99.82
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 99.81
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 99.8
1o6v_A466 Internalin A; bacterial infection, extracellular r 99.8
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 99.8
3rgz_A 768 Protein brassinosteroid insensitive 1; phytohormon 99.8
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 99.78
3rgz_A 768 Protein brassinosteroid insensitive 1; phytohormon 99.77
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 99.76
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 99.76
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 99.76
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 99.75
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 99.75
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 99.74
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 99.74
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 99.74
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 99.72
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 99.72
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 99.71
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 99.71
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 99.7
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 99.7
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 99.7
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 99.7
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 99.68
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 99.68
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 99.68
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 99.67
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 99.67
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 99.67
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 99.67
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 99.66
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 99.66
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 99.65
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 99.65
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 99.64
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 99.63
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 99.6
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 99.6
4g8a_A635 TOLL-like receptor 4; leucine rich repeat MD-2 rel 99.59
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 99.59
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 99.56
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 99.54
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 99.51
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 99.5
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 99.5
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 99.49
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 99.49
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 99.49
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 99.49
4g8a_A 635 TOLL-like receptor 4; leucine rich repeat MD-2 rel 99.48
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 99.47
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 99.47
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 99.46
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 99.46
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 99.45
3g06_A 622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 99.43
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 99.43
3e4g_A176 ATP synthase subunit S, mitochondrial; leucine-ric 99.42
3e4g_A176 ATP synthase subunit S, mitochondrial; leucine-ric 99.42
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 99.42
3g06_A 622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 99.41
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 99.41
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 99.41
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 99.41
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 99.4
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 99.37
4glp_A310 Monocyte differentiation antigen CD14; alpha beta 99.36
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 99.35
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 99.32
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 99.31
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 99.28
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 99.28
4glp_A310 Monocyte differentiation antigen CD14; alpha beta 99.27
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 99.25
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 99.24
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 99.23
3rfs_A272 Internalin B, repeat modules, variable lymphocyte 99.23
3rfs_A272 Internalin B, repeat modules, variable lymphocyte 99.19
4ezg_A197 Putative uncharacterized protein; internalin-A, le 99.18
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 99.16
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 99.16
4ezg_A197 Putative uncharacterized protein; internalin-A, le 99.16
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 99.15
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 99.1
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 99.09
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 99.09
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 99.09
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 99.06
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 99.06
3m19_A251 Variable lymphocyte receptor A diversity region; a 99.01
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 99.01
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 99.01
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 99.0
3m19_A251 Variable lymphocyte receptor A diversity region; a 98.95
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 98.87
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 98.82
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 98.81
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 98.81
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 98.75
3sb4_A329 Hypothetical leucine rich repeat protein; LRR, rig 98.73
3sb4_A329 Hypothetical leucine rich repeat protein; LRR, rig 98.72
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 98.72
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 98.69
2xot_A361 Amphoterin-induced protein 1; cell adhesion, neuro 98.67
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 98.66
2o6s_A208 Variable lymphocyte receptor B; leucine-rich repea 98.64
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 98.63
2xot_A361 Amphoterin-induced protein 1; cell adhesion, neuro 98.62
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 98.59
3e6j_A229 Variable lymphocyte receptor diversity region; var 98.55
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 98.53
3e6j_A229 Variable lymphocyte receptor diversity region; var 98.53
2o6s_A208 Variable lymphocyte receptor B; leucine-rich repea 98.52
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 98.51
3cvr_A 571 Invasion plasmid antigen; leucine rich repeat and 98.51
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 98.49
2v70_A220 SLIT-2, SLIT homolog 2 protein N-product; neurogen 98.47
2v70_A220 SLIT-2, SLIT homolog 2 protein N-product; neurogen 98.47
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 98.47
3cvr_A 571 Invasion plasmid antigen; leucine rich repeat and 98.43
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 98.4
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 98.39
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 98.37
4fdw_A401 Leucine rich hypothetical protein; putative cell s 98.27
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 98.27
2wfh_A193 SLIT homolog 2 protein C-product; developmental pr 98.05
4fs7_A394 Uncharacterized protein; leucine-rich repeats, pro 98.03
1w8a_A192 SLIT protein; signaling protein, secreted protein, 98.0
1w8a_A192 SLIT protein; signaling protein, secreted protein, 97.98
2wfh_A193 SLIT homolog 2 protein C-product; developmental pr 97.94
2o6r_A177 Variable lymphocyte receptor B; leucine-rich repea 97.93
4fdw_A401 Leucine rich hypothetical protein; putative cell s 97.88
2o6r_A177 Variable lymphocyte receptor B; leucine-rich repea 97.84
4gt6_A394 Cell surface protein; leucine rich repeats, putati 97.77
4fs7_A394 Uncharacterized protein; leucine-rich repeats, pro 97.64
4b8c_D 727 Glucose-repressible alcohol dehydrogenase transcr 97.55
4gt6_A394 Cell surface protein; leucine rich repeats, putati 97.52
4b8c_D 727 Glucose-repressible alcohol dehydrogenase transcr 97.5
3g39_A170 Variable lymphocyte receptor VLRB.2D; antibody, X- 97.47
2r9u_A174 Variable lymphocyte receptor; adaptive immunity, V 97.46
3g39_A170 Variable lymphocyte receptor VLRB.2D; antibody, X- 97.29
2r9u_A174 Variable lymphocyte receptor; adaptive immunity, V 97.27
2ifg_A347 High affinity nerve growth factor receptor; TRK, T 96.73
2ifg_A347 High affinity nerve growth factor receptor; TRK, T 96.7
3rw6_A267 Nuclear RNA export factor 1; retroviral constituti 96.65
3rw6_A267 Nuclear RNA export factor 1; retroviral constituti 96.19
4h09_A379 Hypothetical leucine rich repeat protein; two LRR_ 93.12
4h09_A379 Hypothetical leucine rich repeat protein; two LRR_ 92.53
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Back     alignment and structure
Probab=99.97  E-value=6.4e-28  Score=247.35  Aligned_cols=233  Identities=19%  Similarity=0.213  Sum_probs=186.7

Q ss_pred             hCCCCceEEecCCCCCCHHHHHHHHhcCCCCCEEEecCCCCCCHHHHHHhh-CCCCcCEEec--------cCCCCCChHH
Q 011317          184 SCSNLYKLRVSHGTQLTDLVFHDISATSLSLTHVCLRWCNLLTNHAIKSLA-SNTGIKVLDL--------RDCKNLGDEA  254 (488)
Q Consensus       184 ~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~l~-~~~~L~~L~l--------~~~~~~~~~~  254 (488)
                      .+++|++|++++|. +++..+..+...+++|++|++.+|  +.+.++..+. .+++|+.|++        .++..+++.+
T Consensus       287 ~~~~L~~L~L~~~~-l~~~~l~~~~~~~~~L~~L~l~~~--~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~  363 (594)
T 2p1m_B          287 VCSRLTTLNLSYAT-VQSYDLVKLLCQCPKLQRLWVLDY--IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQG  363 (594)
T ss_dssp             HHTTCCEEECTTCC-CCHHHHHHHHTTCTTCCEEEEEGG--GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHH
T ss_pred             hhCCCCEEEccCCC-CCHHHHHHHHhcCCCcCEEeCcCc--cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHH
Confidence            45677777777766 677666767777888888888875  4555555554 5888888888        3445677777


Q ss_pred             HHhhc-CCCCccEEEeCCCccchhHHHHHHhhcCCCccEEecC-----CCCCCC----HHHHHHHhccCCCCCeeEEecC
Q 011317          255 LRAIS-SLPQLKILLLDGSDISDVGVSYLRLTVITSLVKLSLR-----GCKRLT----DKCISALFDGTSKLQLQELDLS  324 (488)
Q Consensus       255 ~~~l~-~~~~L~~L~l~~~~i~~~~~~~l~~~~~~~L~~L~l~-----~~~~l~----~~~~~~l~~~~~~~~L~~L~l~  324 (488)
                      +..+. .+++|++|.+..+.+++.++..+.. .+++|+.|++.     +|..++    +.++..+...+  ++|++|+++
T Consensus       364 l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~-~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~--~~L~~L~L~  440 (594)
T 2p1m_B          364 LVSVSMGCPKLESVLYFCRQMTNAALITIAR-NRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHC--KDLRRLSLS  440 (594)
T ss_dssp             HHHHHHHCTTCCEEEEEESCCCHHHHHHHHH-HCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHC--TTCCEEECC
T ss_pred             HHHHHHhchhHHHHHHhcCCcCHHHHHHHHh-hCCCcceeEeecccCCCcccccCCchhhHHHHHHhhC--CCccEEeec
Confidence            76665 4889999988778888888887775 68999999998     677888    77887777666  899999997


Q ss_pred             CCCCCCHHHHHHHHhcCCCCCeEeecCCCCCCHHHHHHHHcccccCCCCCCCCccEEeccCCCCCCHHHHHHhhccCCCC
Q 011317          325 NLPHLSDNGILTLATCRVPISELRVRQCPLIGDTSVIALASMLVDDDRWYGSSIRLLDLYNCGGITQLAFRWLKKPYFPR  404 (488)
Q Consensus       325 ~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~l~~~~~~~l~~~~~~~~~~~~~~L~~L~l~~~~~i~~~~~~~l~~~~~~~  404 (488)
                      +  .+++.++..+...+++|+.|++++| .+++.++..++.        .+++|++|++++|. +++.++..+.. .+++
T Consensus       441 ~--~l~~~~~~~l~~~~~~L~~L~L~~~-~i~~~~~~~l~~--------~~~~L~~L~L~~n~-~~~~~~~~~~~-~l~~  507 (594)
T 2p1m_B          441 G--LLTDKVFEYIGTYAKKMEMLSVAFA-GDSDLGMHHVLS--------GCDSLRKLEIRDCP-FGDKALLANAS-KLET  507 (594)
T ss_dssp             S--SCCHHHHHHHHHHCTTCCEEEEESC-CSSHHHHHHHHH--------HCTTCCEEEEESCS-CCHHHHHHTGG-GGGG
T ss_pred             C--cccHHHHHHHHHhchhccEeeccCC-CCcHHHHHHHHh--------cCCCcCEEECcCCC-CcHHHHHHHHH-hCCC
Confidence            6  7899998888877999999999999 799999988876        79999999999999 68888876665 5899


Q ss_pred             ccEEEecCCC-CHHHHHHHHhhCCCceeeccc
Q 011317          405 LRWLGVTGSV-NRDILDALARSRPFLNVACRG  435 (488)
Q Consensus       405 L~~L~l~~~~-~~~~~~~~~~~~~~l~~~~~~  435 (488)
                      |+.|++++|. ....+..+....|.+++....
T Consensus       508 L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~  539 (594)
T 2p1m_B          508 MRSLWMSSCSVSFGACKLLGQKMPKLNVEVID  539 (594)
T ss_dssp             SSEEEEESSCCBHHHHHHHHHHCTTEEEEEEC
T ss_pred             CCEEeeeCCCCCHHHHHHHHHhCCCCEEEEec
Confidence            9999999997 466777788889999876544



>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Back     alignment and structure
>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Back     alignment and structure
>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Back     alignment and structure
>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Back     alignment and structure
>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Back     alignment and structure
>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Back     alignment and structure
>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Back     alignment and structure
>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Back     alignment and structure
>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Back     alignment and structure
>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Back     alignment and structure
>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Back     alignment and structure
>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} Back     alignment and structure
>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Back     alignment and structure
>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Back     alignment and structure
>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Back     alignment and structure
>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Back     alignment and structure
>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Back     alignment and structure
>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Back     alignment and structure
>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Back     alignment and structure
>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Back     alignment and structure
>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Back     alignment and structure
>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} Back     alignment and structure
>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Back     alignment and structure
>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Back     alignment and structure
>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Back     alignment and structure
>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Back     alignment and structure
>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A Back     alignment and structure
>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Back     alignment and structure
>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} Back     alignment and structure
>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} Back     alignment and structure
>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} Back     alignment and structure
>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} Back     alignment and structure
>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} Back     alignment and structure
>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Back     alignment and structure
>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Back     alignment and structure
>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Back     alignment and structure
>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Back     alignment and structure
>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Back     alignment and structure
>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Back     alignment and structure
>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} Back     alignment and structure
>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} Back     alignment and structure

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query 488
d2astb2284 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 7e-08
d2astb2284 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 3e-07
d1z7xw1 460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 3e-07
d1z7xw1 460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 7e-06
d1z7xw1 460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 0.003
>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 Back     information, alignment and structure

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]
 Score = 51.6 bits (122), Expect = 7e-08
 Identities = 46/246 (18%), Positives = 85/246 (34%), Gaps = 21/246 (8%)

Query: 206 DISATSLSLTHVCLRWCNLLTNHAIKSLASNTGIKVLDLRDCKNLGDEALRAISSLPQLK 265
           D++   LS   +  R      +  +    S   ++ +DL +           +S   +L+
Sbjct: 15  DVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQ 74

Query: 266 ILLLDGSDISDVGVSYLRLTVITSLVKLSLRGCKRLTDKCISALFDGTSKLQL------- 318
            L L+G  +SD  V+ L     ++LV+L+L GC   ++  +  L    S+L         
Sbjct: 75  NLSLEGLRLSDPIVNTL--AKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCF 132

Query: 319 ----------QELDLSNLPHLSDNGILTLATCRVPISELRVRQCPLIGDTSVIALASMLV 368
                            +  L+ +G           + +R     +  D S   +     
Sbjct: 133 DFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDC 192

Query: 369 DDDRWYGSSIRLLDLYNCGGITQLAFRWLKKPYFPRLRWLGVTGSVNRDILDALARSRPF 428
             + +  + ++ L L  C  I       L +   P L+ L V G V    L  L  + P 
Sbjct: 193 FQEFFQLNYLQHLSLSRCYDIIPETLLELGE--IPTLKTLQVFGIVPDGTLQLLKEALPH 250

Query: 429 LNVACR 434
           L + C 
Sbjct: 251 LQINCS 256


>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure

Homologous Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query488
d2astb2284 Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa 99.9
d2astb2284 Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa 99.9
d1z7xw1460 Ribonuclease inhibitor {Human (Homo sapiens) [TaxI 99.86
d1z7xw1460 Ribonuclease inhibitor {Human (Homo sapiens) [TaxI 99.81
d2ca6a1344 Rna1p (RanGAP1), N-terminal domain {Fission yeast 99.66
d2ca6a1344 Rna1p (RanGAP1), N-terminal domain {Fission yeast 99.65
d2omza2384 Internalin A {Listeria monocytogenes [TaxId: 1639] 99.58
d2omza2384 Internalin A {Listeria monocytogenes [TaxId: 1639] 99.48
d1xkua_305 Decorin {Cow (Bos taurus) [TaxId: 9913]} 99.26
d1h6ua2227 Internalin H {Listeria monocytogenes [TaxId: 1639] 99.13
d1h6ta2210 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.13
d1ozna_284 Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma 99.12
d1h6ua2227 Internalin H {Listeria monocytogenes [TaxId: 1639] 99.1
d1ozna_284 Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma 99.1
d2omxa2199 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.09
d1xkua_305 Decorin {Cow (Bos taurus) [TaxId: 9913]} 99.06
d2omxa2199 Internalin B {Listeria monocytogenes [TaxId: 1639] 98.98
d1h6ta2210 Internalin B {Listeria monocytogenes [TaxId: 1639] 98.96
d1p9ag_266 von Willebrand factor binding domain of glycoprote 98.92
d1p9ag_266 von Willebrand factor binding domain of glycoprote 98.89
d1ogqa_313 Polygalacturonase inhibiting protein PGIP {Kidney 98.87
d1ogqa_313 Polygalacturonase inhibiting protein PGIP {Kidney 98.85
d1pgva_167 Tropomodulin C-terminal domain {nematode (Caenorha 98.77
d1io0a_166 Tropomodulin C-terminal domain {Chicken (Gallus ga 98.69
d1jl5a_353 Leucine rich effector protein YopM {Yersinia pesti 98.63
d1a9na_162 Splicesomal U2A' protein {Human (Homo sapiens) [Ta 98.59
d1pgva_167 Tropomodulin C-terminal domain {nematode (Caenorha 98.58
d1xwdc1242 Follicle-stimulating hormone receptor {Human (Homo 98.57
d1a9na_162 Splicesomal U2A' protein {Human (Homo sapiens) [Ta 98.56
d1m9la_198 Outer arm dynein light chain 1 {Green algae (Chlam 98.46
d1io0a_166 Tropomodulin C-terminal domain {Chicken (Gallus ga 98.45
d1xwdc1242 Follicle-stimulating hormone receptor {Human (Homo 98.43
d1m9la_198 Outer arm dynein light chain 1 {Green algae (Chlam 98.31
d1dcea3124 Rab geranylgeranyltransferase alpha-subunit, C-ter 98.3
d1dcea3124 Rab geranylgeranyltransferase alpha-subunit, C-ter 98.23
d1jl5a_353 Leucine rich effector protein YopM {Yersinia pesti 98.19
d1w8aa_192 Slit {Fruit fly (Drosophila melanogaster) [TaxId: 98.06
d1w8aa_192 Slit {Fruit fly (Drosophila melanogaster) [TaxId: 98.0
d2ifga3156 High affinity nerve growth factor receptor, N-term 97.23
d2ifga3156 High affinity nerve growth factor receptor, N-term 97.06
d1koha1162 mRNA export factor tap {Human (Homo sapiens) [TaxI 96.74
d1koha1162 mRNA export factor tap {Human (Homo sapiens) [TaxI 96.32
>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90  E-value=2.8e-23  Score=189.04  Aligned_cols=250  Identities=18%  Similarity=0.262  Sum_probs=188.8

Q ss_pred             CEEEEcCCCCCCHHHHHHHHHhCCCCceEEecCCCCCCHHHHHHHHhcCCCCCEEEecCCCCCCHHHHHH-hhCCCCcCE
Q 011317          163 ESICLGGFCRVTDTGFKTILHSCSNLYKLRVSHGTQLTDLVFHDISATSLSLTHVCLRWCNLLTNHAIKS-LASNTGIKV  241 (488)
Q Consensus       163 ~~L~l~~~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~-l~~~~~L~~  241 (488)
                      ++||+++ ..+....+..+...  .+..+.++.... .. +.. ......+|++|++++| .+....+.. +..+++|++
T Consensus         3 ~~lDLs~-~~l~~~~l~~l~~~--~~~~lrl~~~~~-~~-~~~-~~~~~~~L~~LdLs~~-~i~~~~l~~l~~~c~~L~~   75 (284)
T d2astb2           3 QTLDLTG-KNLHPDVTGRLLSQ--GVIAFRCPRSFM-DQ-PLA-EHFSPFRVQHMDLSNS-VIEVSTLHGILSQCSKLQN   75 (284)
T ss_dssp             SEEECTT-CBCCHHHHHHHHHT--TCSEEECTTCEE-CS-CCC-SCCCCBCCCEEECTTC-EECHHHHHHHHTTBCCCSE
T ss_pred             CEEECCC-CCCCchHHHHHHhc--cceEeecccccc-cc-chh-hhccCCCCCEEECCCC-ccCHHHHHHHHHhCCCccc
Confidence            4567776 45555545554432  334444433211 00 000 0113347888888875 555555444 447888888


Q ss_pred             EeccCCCCCChHHHHhhcCCCCccEEEeCCC-ccchhHHHHHHhhcCCCccEEecCCCCCCCHHHHHHHh-ccCCCCCee
Q 011317          242 LDLRDCKNLGDEALRAISSLPQLKILLLDGS-DISDVGVSYLRLTVITSLVKLSLRGCKRLTDKCISALF-DGTSKLQLQ  319 (488)
Q Consensus       242 L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-~i~~~~~~~l~~~~~~~L~~L~l~~~~~l~~~~~~~l~-~~~~~~~L~  319 (488)
                      |++++| .+.+..+..++.+++|++|++++| .+++.++..+.. .+++|++|++++|..+++.++.... ..+  ++|+
T Consensus        76 L~L~~~-~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~-~~~~L~~L~ls~c~~~~~~~~~~~~~~~~--~~L~  151 (284)
T d2astb2          76 LSLEGL-RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLS-SCSRLDELNLSWCFDFTEKHVQVAVAHVS--ETIT  151 (284)
T ss_dssp             EECTTC-BCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHH-HCTTCCEEECCCCTTCCHHHHHHHHHHSC--TTCC
T ss_pred             cccccc-CCCcHHHHHHhcCCCCcCccccccccccccccchhhH-HHHhccccccccccccccccchhhhcccc--cccc
Confidence            888887 577777778888888888888886 788888887776 6899999999999889988776543 334  7899


Q ss_pred             EEecCCC-CCCCHHHHHHHHhcCCCCCeEeecCCCCCCHHHHHHHHcccccCCCCCCCCccEEeccCCCCCCHHHHHHhh
Q 011317          320 ELDLSNL-PHLSDNGILTLATCRVPISELRVRQCPLIGDTSVIALASMLVDDDRWYGSSIRLLDLYNCGGITQLAFRWLK  398 (488)
Q Consensus       320 ~L~l~~~-~~l~~~~~~~l~~~~~~L~~L~l~~~~~l~~~~~~~l~~~~~~~~~~~~~~L~~L~l~~~~~i~~~~~~~l~  398 (488)
                      +|++++| ..+++.++..+...||+|++|++++|..+++.++..+.         .+++|++|++++|..+++.++..+.
T Consensus       152 ~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~---------~~~~L~~L~L~~C~~i~~~~l~~L~  222 (284)
T d2astb2         152 QLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFF---------QLNYLQHLSLSRCYDIIPETLLELG  222 (284)
T ss_dssp             EEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGG---------GCTTCCEEECTTCTTCCGGGGGGGG
T ss_pred             hhhhcccccccccccccccccccccccccccccccCCCchhhhhhc---------ccCcCCEEECCCCCCCChHHHHHHh
Confidence            9999987 46889999999888999999999999889998887776         6899999999999989998888887


Q ss_pred             ccCCCCccEEEecCCCCHHHHHHHHhhCCCceeecc
Q 011317          399 KPYFPRLRWLGVTGSVNRDILDALARSRPFLNVACR  434 (488)
Q Consensus       399 ~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~l~~~~~  434 (488)
                      .  +|+|+.|++++|.....+..+....|.+++.+.
T Consensus       223 ~--~~~L~~L~l~~~~~d~~l~~l~~~lp~L~i~~~  256 (284)
T d2astb2         223 E--IPTLKTLQVFGIVPDGTLQLLKEALPHLQINCS  256 (284)
T ss_dssp             G--CTTCCEEECTTSSCTTCHHHHHHHSTTSEESCC
T ss_pred             c--CCCCCEEeeeCCCCHHHHHHHHHhCccccccCc
Confidence            5  999999999999888889999999999998654



>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Back     information, alignment and structure
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Back     information, alignment and structure
>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Back     information, alignment and structure
>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Back     information, alignment and structure
>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Back     information, alignment and structure
>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Back     information, alignment and structure
>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Back     information, alignment and structure
>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Back     information, alignment and structure
>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Back     information, alignment and structure
>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure